BIOMAT Database Logo BIOMAT Database Logo

[Observations & results in patients with malignant hemolymphatic diseases treated with p-(N,N-di-2-chloroethyl) aminophenylbutyric acid (CB 1348)]. 1959

V PERRONE, and A FAIELLA, and D ZARRILLI

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008466 Mechlorethamine A biologic alkylating agent that exerts its cytotoxic effects by forming DNA ADDUCTS and DNA interstrand crosslinks, thereby inhibiting rapidly proliferating cells. The hydrochloride is an antineoplastic agent used to treat HODGKIN DISEASE and LYMPHOMA. Chlorethazine,Chlormethine,Mechlorethamine Oxide,Mustine,Nitrogen Mustard,Nitrogen Mustard N-Oxide,Bis(2-chloroethyl)methylamine,Caryolysine,Cloramin,Embichin,Mechlorethamine Hydrochloride,Mechlorethamine Hydrochloride N-Oxide,Mechlorethamine N-Oxide,Methylchlorethamine,Mitomen,Mustargen,NSC-10107,NSC-762,Nitrogranulogen,Nitromin,Hydrochloride N-Oxide, Mechlorethamine,Hydrochloride, Mechlorethamine,Mechlorethamine Hydrochloride N Oxide,Mechlorethamine N Oxide,N-Oxide, Mechlorethamine Hydrochloride,N-Oxide, Nitrogen Mustard,NSC 10107,NSC 762,NSC10107,NSC762,Nitrogen Mustard N Oxide
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009588 Nitrogen Mustard Compounds A group of alkylating agents derived from mustard gas, with the sulfur replaced by nitrogen. They were formerly used as toxicants and vesicants, but now function as antineoplastic agents. These compounds are also powerful mutagens, teratogens, immunosuppressants, and carcinogens. Compounds, Nitrogen Mustard,Mustard Compounds, Nitrogen
D002699 Chlorambucil A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed) 4-(Bis(2-chloroethyl)amino)benzenebutanoic Acid,Amboclorin,CB-1348,Chloraminophene,Chlorbutin,Leukeran,Lympholysin,N,N-Di-(2-chloroethyl)-p-aminophenylbutyric Acid,NSC-3088,CB 1348,CB1348,NSC 3088,NSC3088

Related Publications

V PERRONE, and A FAIELLA, and D ZARRILLI
[p-(N, N-Di-2-chloroethyl)-aminophenylbutyric acid (CB-1348) in oncological therapy].
September 1960, La Clinica terapeutica,
V PERRONE, and A FAIELLA, and D ZARRILLI
[Results of p-(di-2-chloroethyl) aminophenylbutyric acid (CB 1348) therapy of several malignant tumors in children].
January 1956, Boletin medico del Hospital Infantil de Mexico,
V PERRONE, and A FAIELLA, and D ZARRILLI
P-(Di-2-chloroethyl) aminophenylbutyric acid (CB 1348) in the treatment of cancer.
April 1958, Annals of the New York Academy of Sciences,
V PERRONE, and A FAIELLA, and D ZARRILLI
Clinical experience with CB 1348 (NN-di(2-chloroethyl, -P-aminophenylbutyric acid) in the treatment of chronic lymphatic leukaemia.
March 1957, Acta radiologica,
V PERRONE, and A FAIELLA, and D ZARRILLI
Early experience with p-(N, N-di-2-chloroethyl)-aminophenylbutyric acid (CB 1348), a new chemotherapeutic agent effective in the treatment of chronic lymphocytic leukemia.
January 1956, Cancer,
V PERRONE, and A FAIELLA, and D ZARRILLI
Clinical trials of p-(di-2-chloroethylamino)-phenylbutyric acid (CB 1348) in malignant lymphoma.
November 1955, British medical journal,
V PERRONE, and A FAIELLA, and D ZARRILLI
[Results of therapy with chlorambucil (N,N-bis-(2-chloroethyl)-p-aminophenylbutyric acid) in lymphatic systemic diseases, reticuloses and related diseases].
June 1961, Die Medizinische Welt,
V PERRONE, and A FAIELLA, and D ZARRILLI
Reactions of N,N-bis(2-chloroethyl)-p-aminophenylbutyric acid (chlorambucil) with 2'-deoxyguanosine.
August 2001, Chemical research in toxicology,
V PERRONE, and A FAIELLA, and D ZARRILLI
Reactions of N,N-bis(2-chloroethyl)-p-aminophenylbutyric acid (chlorambucil) with 2'-deoxyadenosine.
March 2003, Chemical research in toxicology,
V PERRONE, and A FAIELLA, and D ZARRILLI
[Clinical experience with the use of p-(N,N-di-2-chloroethyl) aminophenylbutyric acid in the chemotherapy of various hemolymphoblastoses].
February 1958, Il Progresso medico,
Copied contents to your clipboard!